PolTREG

PolTREG

Pre-clinical
Gdańsk, PolandFounded 2011poltreg.bio

PTG007, a potential disease-modifying treatment for Type-1 Diabetes and Multiple Sclerosis

Founded
2011
Focus
Cell & Gene Therapy

About

PTG007, a potential disease-modifying treatment for Type-1 Diabetes and Multiple Sclerosis

Funding History

2

Total raised: $16M

Series A$10MMedicoverJun 15, 2021
Grant$6MEuropean UnionJun 15, 2020

Company Info

TypePrivate
Founded2011
LocationGdańsk, Poland
StagePre-clinical
SIMILAR COMPANIES
AILIS Breast Cancer
AILIS Breast Cancer
Pre-clinical · Warsaw
Biocam
Biocam
Pre-clinical · Warsaw
Bioton
Bioton
Pre-clinical · Warsaw
Ensera
Ensera
Pre-clinical · Warsaw
Biovico
Biovico
Pre-clinical · Warsaw
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile